| pubmed-article:21732835 | pubmed:abstractText | Nesiritide is approved in the United States for early relief of dyspnea in patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and the mortality associated with this agent. | lld:pubmed |
